Search results
Novartis AG (NYSE:NVS) Shares Sold by Cannell & Co.
ETF DAILY NEWS· 5 hours agoCannell & Co. trimmed its holdings in shares of Novartis AG (NYSE:NVS – Free Report) by 19.2% in the 4th quarter, according to the company in its most recent 13F filing with ...
Novartis to buy radiology specialist Mariana Oncology for $1 billion
Reuters· 1 day agoNovartis has entered an agreement to acquire US radiopharmaceutical company Mariana Oncology for $1...
Novartis to Buy Mariana Oncology, Paying $1 Billion Upfront
Bloomberg· 1 day agoNovartis agreed to buy US biotech Mariana Oncology Inc. to strengthen its pipeline of drugs that can...
Novartis to pay up to $1.75 billion for U.S. cancer-focused biotech
Market Watch· 1 day agoPharmaceutical giant Novartis AG on Thursday said it will pay up to $1.75 billion for a U.S. biotech...
Novartis further entrenches into radiopharma with $1B Mariana buy
FierceBiotech· 1 day agoWith much still to discover in the massive world of radiopharmaceuticals, Novartis will take a deep...
Novartis to buy Mariana Oncology in radiopharmaceutical expansion
BioPharma Dive via Yahoo Finance· 1 day agoDive Brief: Novartis is expanding its pipeline of radiopharmaceutical drugs, announcing Thursday it...
Novartis to Buy Mariana Oncology for Up to $1.75 Billion in Boost to Radioligand Therapy Business
Morningstar· 1 day agoBy Mauro Orru Novartis agreed to acquire U.S. biotechnology company Mariana Oncology for up to $1.75 billion, in a deal that bolsters its radioligand therapy pipeline and ...
Novartis Is Tracking Well Above the Industry
GuruFocus.com via Yahoo Finance· 2 days agoNovartis AG (NYSE:NVS) is one of the largest pharmaceutical companies in the world, many of whose drugs are "gold standards" in the treatment of cancer,...
Novartis pays PeptiDream $180M as radiopharma big bang continues
FierceBiotech· 3 days agoNovartis is pumping another $180 million into its radioligand plan, handing the cash to serial dealmaker PeptiDream to expand (PDF) a peptide-drug conjugate (PDC) collaboration ...
The top pharmaceutical companies by R&D expenditure
Pharmaceutical Technology via Yahoo Finance· 1 day agoMerck & Co- $30.5bn Roche- $15.56bn (CHF 14.20bn) Johnson & Johnson- $15.09bn Novartis- $ 11.37bn AstraZeneca- $10.94bn Pfizer- $10.58bn Eli Lilly-...
